Egypt’s Grinta Secures Funding, Acquires Citi Clinic In Strategic Healthcare Pivot

Egyptian health-tech startup Grinta has raised an undisclosed funding round from Beltone Venture Capital and Raed Ventures, marking a major step in its transition from a B2B pharmaceutical marketplace to a hybrid healthcare provider.

Founded in 2021 by Mohamed Azab, Yosra Badr, Ali Youssef, and Hamza Mohamed, Grinta originally provided pharmacies with traceable medical products, fulfilment, and inventory financing. Now, with the acquisition of Citi Clinic, a primary healthcare chain serving 150,000+ patients, the company is shifting focus to direct patient care by integrating online and offline healthcare services.

CEO Mohamed Azab called the move a “pivotal moment”, aligning Grinta with global players like McKesson and Walgreens, who have successfully expanded from distribution into direct healthcare services. The company is also exiting its B2B retail pharmaceutical distribution business in Egypt to focus entirely on patient care.

With new capital, Grinta plans to expand into East Africa, partner with Egyptian pharmaceutical manufacturers, and build a pharmacy chain in Tanzania. Investors, including Ali Mokhtar (Beltone Venture Capital) and Wael Nafee (Raed Ventures), expressed confidence in Grinta’s ability to reshape healthcare access across emerging markets.